Affinity Asset Advisors »

Belite Bio shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.2M 20k 159.96

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Belite Bio

Darwin Global Management
RA Capital Management
Rtw Investments
Eventide Asset Management
Vestal Point Capital
Point72 Asset Management
Deerfield Management Company
Marshall Wace
UBS Group
MPM Oncology Impact Management
Holocene Advisors
Western Standard
Perceptive Advisors
Goldman Sachs Group
Soleus Capital Management

View all funds holding Belite Bio